Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2017
Price : $35 *
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer; Gastric cancer
- Focus Pharmacokinetics
- Sponsors Meiji Seika Pharma
- 12 Dec 2015 Results published in the BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
- 09 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jul 2014 Planned End Date changed from 1 May 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.